Effect of pioglitazone on AGE-BSA induced proliferation and plasminogen activator inhibitor-1 mRNA expression of rat vascular smooth muscle cells

YUAN Xiao-chen,LIU Nai-feng,LI Ai-hua

2007-01-01

Abstract:Objective To observe the effects of pioglitazone on advanced glycation end products (AGEs)-induced proliferation and expression of plasminogen activator inhibitor-1(PAI-1) mRNA of rat aorta vascular smooth muscle cells (VSMCs). Methods Smooth muscle cells of primary culture from rat aorta were exposed to AGEs in different concentrations and different times, then exposed to co-treatment of AGEs (200 mg/L) with different doses of pioglitazone for 24 hours. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay was adopted for the quantification of the cell proliferation ratio, and PAI-1 mRNA expression was determined by reverse-transcription polymerase chain reaction (RT-PCR). Results Pioglitazone inhibited the AGEs-induced proliferation of VSMCs. AGEs treatment of VSMCs increased mRNA levels of PAI-1, in a time-and dose-dependent manner (P<0.05). Pioglitazone obviously inhibited the AGEs-induced PAI-1 expression. Conclusions Antidiabetic agent pioglitazone might be beneficial for preventing atherosclerosis through inhibiting both vascular smooth muscle cell proliferation and the expression of PAI-1 in patients with diabetes mellitus.